Juan Graham
CIK: 0001879223
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 28, 2025CATX
Perspective Therapeutics, Inc.
Purchase(P)Direct33.3K shares at avg. $2.25$75K - Jan 6, 2025CATX
Perspective Therapeutics, Inc.
Award(A)DirectStock option (right to buy)
400K shares- - Dec 7, 2024FGEN
FIBROGEN INC
Tax Payment(F)Direct1.1K shares at avg. $0.34$364.679 - Dec 6, 2024FGEN
FIBROGEN INC
Tax Payment(F)Direct1.4K shares at avg. $0.34$494.677 - Sep 7, 2024FGEN
FIBROGEN INC
Tax Payment(F)Direct1.1K shares at avg. $0.39$415.35 - Sep 6, 2024FGEN
FIBROGEN INC
Tax Payment(F)Direct16.1K shares at avg. $0.39$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 28, 2025 | CATX Perspective Therapeutics, Inc. | Purchase(P) | 33,333 | $2.25 | $74,946 | Direct |
| Jan 6, 2025 | CATX Perspective Therapeutics, Inc. | Award(A) Stock option (right to buy) | 400,000 | - | - | Direct |
| Dec 7, 2024 | FGEN FIBROGEN INC | Tax Payment(F) | 1,066 | $0.34 | $365 | Direct |
| Dec 6, 2024 | FGEN FIBROGEN INC | Tax Payment(F) | 1,446 | $0.34 | $495 | Direct |
| Sep 7, 2024 | FGEN FIBROGEN INC | Tax Payment(F) | 1,065 | $0.39 | $415 | Direct |
| Sep 6, 2024 | FGEN FIBROGEN INC | Tax Payment(F) | 16,050 | $0.39 | $6,260 | Direct |
1-6 of 6 transactions
About Graham Juan
Graham Juan (SEC CIK 0001879223) files insider reports with the SEC as Chief Financial Officer of Perspective Therapeutics, Inc. (CATX) and CHIEF FINANCIAL OFFICER of FIBROGEN INC (FGEN).
Signal8 holds 5 ownership filings by Graham Juan (1 Form 3, 4 Form 4), filed between Sep 9, 2024 and Apr 1, 2025. Those filings report 6 transactions, from Sep 6, 2024 to Mar 28, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Graham Juan's filings is in SEATTLE, WA.
Recent filings by Graham Juan
- Mar 28, 2025: Open-market purchase of CATX shares (Form 4, code P).
- Jan 6, 2025: Grant or award of CATX derivative securities (Form 4, code A).
- Dec 7, 2024: Tax withholding of FGEN shares (Form 4, code F).
- Dec 6, 2024: Tax withholding of FGEN shares (Form 4, code F).
- Sep 7, 2024: Tax withholding of FGEN shares (Form 4, code F).
Other insiders filing for Perspective Therapeutics, Inc. (CATX)
- Lantheus Alpha Therapy, LLC, 10% Owner
- Lantheus Holdings, Inc., 10% Owner
- Martinez Maria E, Director
- Morich Frank, Director
- Williamson Robert F III, Director
- HENSON HEIDI, Director